$ACCS

ACCESS Newswire (ACCS) Q2 2026 Earnings Call Transcript

Access Newswire (ACCS) reported Q2 2026 total revenue of $5.6 million, up 5% sequentially and flat vs Q2 2025. Subscription ARR per customer rose to $12,718 (+15% YoY). Gross margin was 73% and operating loss $307,000. Adjusted EBITDA was $0.6 million. Cash was just under $3 million; it repurchased 40,000 shares.

Original reporting
Published Aug 12, 2026, 1:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 1:28 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ACCESS Newswire (ACCS) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ACCSBullishMed
01

Why it matters

Investors can update expectations for subscription monetization and margin trajectory using the disclosed ARR per customer, revenue mix, gross margin drivers, and cost initiatives for the back half of 2026.

02

Market read

The call provides concrete operating metrics (ARR per customer, revenue, gross margin drivers, adjusted EBITDA, and buyback activity) that can drive near-term positioning.

03

What to watch

The transcript notes lower webcasting and ProPlan revenue and variable-contract usage driving higher distribution costs; traders may discount ARR per customer if it does not translate into sustained top-line acceleration.

Relevance 7/10Novelty 6/10Timing: today, earnings call transcript with Q2 and first-half 2026 financial datapoints

Background

ACCESS Newswire (ACCS) held an earnings call transcript covering Q2 2026 and first-half 2026 results, plus capital allocation via share repurchases and product roadmap updates.

Company-level read

Ticker impact

$ACCSBullishMedium confidence
Context

ACCS reported Q2 2026 results, including $5.6M revenue, subscription ARR per customer of $12,718, and ongoing share repurchases.

Expected impact

Likely modest positive bias for the stock if investors focus on subscription tiering progress and adjusted EBITDA strength, but magnitude depends on market expectations for growth.

Evidence & confidence

The article provides multiple concrete operating metrics (ARR per customer, revenue mix, gross margin drivers, adjusted EBITDA, and buyback activity) that can be used to update models, though it does not include explicit forward guidance numbers beyond product cadence and cost initiatives.

Market effects

Signals ongoing investment in subscription tiering and product-led growth for media/press-release and analytics-style SaaS, with emphasis on cost-of-revenue management.

None explicit.

None explicit.

Counterpoint

Revenue is essentially flat YoY in Q2 and down slightly in the first half, while gross margin percentage fell due to higher distribution costs, which could limit upside despite ARR per customer gains.

Key entities

  • ACCESS Newswire

    Subject of the earnings call transcript, reporting Q2 2026 financial results and subscription metrics.

  • Steve Knerr

    Speaker who walked through Q2 and first-half 2026 financial results and margin/cost details.

  • Brian Balbirnie

    Speaker who discussed capital allocation, including share repurchases, and priorities for the second half of 2026.

Related articles

$ACCSMed

ACCESS Newswire Reports Second Quarter 2026 Results

ACCESS Newswire Inc. (ACCS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ACCESS Newswire Reports Second Quarter 2026 Results Average ARR and cashflow from operations continue to increase over PY, as Adjusted EBITDA remains positive · Average ARR for subscriptions per customer at the end of Q2 2026 increased to $12,718, up from $11,039 at

$ACCSMed

ACCESS Newswire Inc.: ACCESS Newswire Reports Second Quarter 2026 Results

ACCESS Newswire Inc. (NYSE American:ACCS) reported Q2 2026 results: revenue rose to $5.6M from $5.3M in Q1 2026 and matched Q2 2025. Gross margin fell to 73% from 76% in Q2 2025. Adjusted EBITDA was $642k versus $836k a year earlier. Average ARR per subscription customer increased to $12,718. The company also reported a Q2 operating loss of $0.3M and cash flow from operations of $173k.

$RDYMed

Dr Reddy's Laboratories Ltd (RDY) (Q2 2027) Earnings Call Highlights: Margin Recovery

Dr. Reddy's Laboratories reported a 1.5% year-over-year revenue decline, driven by lower lenalidomide sales and declines in North America, Europe, and PSAI businesses. The company expects margins to improve with new products and business mix, targeting a 55% gross margin. Semaglutide relaunch is planned for November 2026, and abatacept biosimilar approval is expected by December 2026.

$BCSMedAI 8/10

Barclays Posts £2.3bn Q3 Profit and Plans 5,000 Job Cuts

Barclays reported a 12% rise in Q3 pre-tax profit to £2.3bn, driven by revenue growth and lower impairment charges. The bank announced a £500m share buyback and plans to cut 5,000 jobs. Revenue increased 3% to £7.4bn, while earnings per share rose 18%. Trading revenues showed mixed results, with equities up 47% and fixed income down 19%. Shares fell over 2.5% post-announcement.

$FIXMed

Comfort Systems USA Inc (FIX) (Q3 2026) Earnings Call Highlights: Record

Comfort Systems USA (FIX) reported Q3 2026 earnings, with record bookings driven by new and existing customers. Gross margins declined due to higher equipment/materials costs and purchase accounting adjustments. Backlog duration extended to 18-24 months, potentially delaying revenue recognition. Labor constraints and high acquisition pricing were noted. The company expects margin normalization in early 2027 and remains cautious about adding new programmatic modular customers.

$ALVHighAI 8/10

Autoliv Inc (ALV) (Q3 2026) Earnings Call Highlights: Margin Resilience

Autoliv Inc (ALV) reported Q3 2026 adjusted operating margin of 9.7%, exceeding expectations despite a 1.9% global light vehicle production decline. Sales grew in Asia, with strong cash flow and shareholder returns. The company expects Q4 margin expansion but narrowed full-year margin guidance to around 10.5% due to cost pressures. Raw material and logistics costs negatively impacted margins, with challenges expected to persist into 2027.